von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

MLA

Masanori Matsumoto, et al. “Von Willebrand Factor Is a Useful Biomarker for Liver Fibrosis and Prediction of Hepatocellular Carcinoma Development in Patients with Hepatitis B and C.” United European Gastroenterology Journal, vol. 6, no. 9, Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....adbb0dd46507a1e85d86460aa27ada06&authtype=sso&custid=ns315887.

APA

Masanori Matsumoto, Takemi Akahane, Keisuke Nakanishi, Hiroaki Takaya, Yasushi Okura, Kosuke Kaji, Yasuhiko Sawada, Kei Moriya, Mitsuteru Kitade, Akira Mitoro, Hideto Kawaratani, Tadashi Namisaki, Naotaka Shimozato, Soichiro Saikawa, Yuki Tsuji, Shinya Sato, Hitoshi Yoshiji, & Hiroshi Fukui. (2018). von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C. United European Gastroenterology Journal, 6(9).

Chicago

Masanori Matsumoto, Takemi Akahane, Keisuke Nakanishi, Hiroaki Takaya, Yasushi Okura, Kosuke Kaji, Yasuhiko Sawada, et al. 2018. “Von Willebrand Factor Is a Useful Biomarker for Liver Fibrosis and Prediction of Hepatocellular Carcinoma Development in Patients with Hepatitis B and C.” United European Gastroenterology Journal 6 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....adbb0dd46507a1e85d86460aa27ada06&authtype=sso&custid=ns315887.